A detailed history of Saturn V Capital Management LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Saturn V Capital Management LLC holds 814,533 shares of IRWD stock, worth $1.16 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares
814,533
Previous 1,120,409 27.3%
Holding current value
$1.16 Million
Previous $4.62 Billion 21.83%
% of portfolio
1.41%
Previous 1.65%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$3.34 - $5.04 $1.02 Million - $1.54 Million
-305,876 Reduced 27.3%
814,533 $3.61 Billion
Q3 2024

Nov 14, 2024

BUY
$3.93 - $7.04 $25,879 - $46,358
6,585 Added 0.59%
1,120,409 $4.62 Billion
Q2 2024

Aug 14, 2024

BUY
$5.58 - $8.61 $942,528 - $1.45 Million
168,912 Added 17.88%
1,113,824 $7.26 Billion
Q1 2024

May 15, 2024

BUY
$8.32 - $15.45 $7.86 Million - $14.6 Million
944,912 New
944,912 $8.23 Billion

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $219M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Saturn V Capital Management LLC Portfolio

Follow Saturn V Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saturn V Capital Management LLC with notifications on news.